Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Investigation of the newly characterized baimantuoluoamide A and baimantuoluoamide B alkaloids as potential cyclin-dependent kinase 4 (CDK4) inhibitors using molecular docking and molecular dynamics simulations (CROSBI ID 288390)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Gurushankar, Krishnamurti ; Rimac, Hrvoje ; Potemkin, Vladimir ; Grishina, Maria Investigation of the newly characterized baimantuoluoamide A and baimantuoluoamide B alkaloids as potential cyclin-dependent kinase 4 (CDK4) inhibitors using molecular docking and molecular dynamics simulations // Journal of molecular structure, 1230 (2021), 129925, 8. doi: 10.1016/j.molstruc.2021.129925

Podaci o odgovornosti

Gurushankar, Krishnamurti ; Rimac, Hrvoje ; Potemkin, Vladimir ; Grishina, Maria

engleski

Investigation of the newly characterized baimantuoluoamide A and baimantuoluoamide B alkaloids as potential cyclin-dependent kinase 4 (CDK4) inhibitors using molecular docking and molecular dynamics simulations

CDK4 is an enzyme often associated with various forms of cancer. Since an abnormal function of the CDK4-cyclin D1 protein complex can play a pivotal role in causing various types of cancer, CDK4 is considered an important therapeutic target. Traditionally, herbal medicines have played a vital role in the treatment of many diseases and ailments. Likewise, D. stramonium, Solanaceae, possesses the cytotoxic, anti-inflammatory, anti- viral, antibacterial, antioxidant, analgesic, antiulcer, and insecticidal properties which are a result of its phytoconstituents. Baimantuoluoamide A and baimantuoluoamide B are newly isolated Datura metel L. phytoconstituents, whose molecular interactions are still unknown. Additionally, an experimentally determined crystal structure of baimantuoluoamide A and baimantuoluoamide B bound to CDK4 has not yet been reported. Thus, this study aimed to identify the residues in the baimantuoluoamide A and baimantuoluoamide B-CDK4 binding interface. For this purpose, molecular docking, molecular dynamics (MD) simulations and the MM/GBSA method to identify the binding modes and crucial residues were employed. The results obtained in the current study will provide valuable guidelines for developing novel potent and selective CDK4 inhibitors.

D. stramonium ; D. metel L ; Baimantuoluoamide A ; Baimantuoluoamide B ; ChemoSophia ; CDK4 ; MM/GBSA ; 3D/4D QSAR ; Molecular Dynamics ; Molecular Docking

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

1230

2021.

129925

8

objavljeno

0022-2860

1872-8014

10.1016/j.molstruc.2021.129925

Povezanost rada

Farmacija, Interdisciplinarne prirodne znanosti, Kemija

Poveznice
Indeksiranost